| Recently, the French medical device company Gecko Biomedical received € 6 million ($ 7.4 million) from the PIA, a fund that will be used primarily to promote private use for tissue remodeling and peripheral nerve therapies Development and industrialization of biological 3D printing polymers.  The Paris-based company is currently developing an 'exclusive platform' for biomedical 3D printed synthetic polymers that is said to enable tissue remodeling while biocompatible and bioabsorbable materials are designed to stick during surgery Attach to internal organization to help natural reconstruction of patient organization. Gecko Biomedical uses 3D printing materials as a 'barrier or sealant' that can be used to reconstruct the tissue during and after surgery. In addition, the company says the tissue implant is designed to be "activated" by a specific type of light , And 3D printing can be done at high resolution for best efficiency. The EUR 6 million grant from PIA has been awarded to the Gecko PIAVE project proposal in cooperation with SGPI and investment bank Bpifrance, R & D program, especially for the treatment of the peripheral nervous system. The company is also currently building a 1,150-square-meter production facility in Roncq, France, which will be fully powered by green energy and will consist of four clean rooms (over 300 square meters) and an analytical laboratory (over 240 square meters) composition. Christophe Bancel, CEO of Gecko Biomedical, commented: 'This funding will enable us to accelerate the process of industrialization and provide us with a globally unique production site where we will carry out advanced production processes to produce all of our Liquid polymer for use by surgeons under sterile conditions. 'We also intend to accelerate the second phase of our strategy through the industrial and clinical development of our 3D printing platform by utilizing our polymers as biomedical resins and optimizing the flexibility of state-owned medical institutions with state-of-the-art 3D printing technology , Bioabsorbable and high resolution implants, 'he added. Marie Zwarg, head of health care at Bpifrance Industries, expressed her passion for the project: 'Bpifrance has been supporting Gecko Biomedical since its inception and we are excited to contribute to the development of the state-of-the-art technology platform that drives a wide range of applications, Contribute to the industrialization. Article Source: 3D Tiger |
 |
|